Pricing Log in Create free account

CervoMed Inc. (CRVO) vs Cel-Sci Corporation (CVM)

CervoMed Inc. and Cel-Sci Corporation are both Biotechnology companies. CervoMed Inc. and Cel-Sci Corporation are of similar size ($24.1M and $21.9M). Cel-Sci Corporation grew revenue faster over the last twelve months: 20.8% against −58.9%. Across the 14 metrics below, CervoMed Inc. leads on 9 and Cel-Sci Corporation on 5.

Valuation

Metric CRVO CVM Biotechnology median
P/E n/m n/m 10.60
P/S 3.61 31.44 9.40
P/B 0.63 1.60 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.62 27.64 9.02
Earnings yield (228.37%) (184.94%) (32.88%)
Free cash flow yield (196.71%) (95.61%) (23.13%)

Profitability

Metric CRVO CVM Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (107.62%) (252.53%) (51.96%)
Return on assets (94.73%) (108.91%) (46.06%)
Return on invested capital 0.00% (169.59%) 0.00%

Growth

Metric CRVO CVM Biotechnology median
Revenue growth (TTM) (58.86%) 20.75% 6.76%
EPS growth (last fiscal year) (47.52%) 59.06% 29.88%
Revenue growth, 5-year CAGR — 16.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVO CVM Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 8.57 1.48 4.97
Net debt to EBITDA 0.74 0.25 1.01

Dividend

Metric CRVO CVM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRVO CVM Biotechnology median
Market cap 21.93m 24.09m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack